These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7935506)

  • 1. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.
    Huang W; Nardelli B; Tam JP
    Mol Immunol; 1994 Oct; 31(15):1191-9. PubMed ID: 7935506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity.
    Defoort JP; Nardelli B; Huang W; Tam JP
    Int J Pept Protein Res; 1992; 40(3-4):214-21. PubMed ID: 1478779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide.
    Nardelli B; Tam JP
    Immunology; 1993 Jul; 79(3):355-61. PubMed ID: 8104882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular assemblage in the design of a synthetic AIDS vaccine.
    Defoort JP; Nardelli B; Huang W; Ho DD; Tam JP
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3879-83. PubMed ID: 1349173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses.
    Nardelli B; Haser PB; Tam JP
    Vaccine; 1994 Nov; 12(14):1335-9. PubMed ID: 7856301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
    Babu JS; Nair S; Kanda P; Rouse BT
    Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes.
    Chang JS; Choi MJ; Kim TY; Cho SY; Cheong HS
    Vaccine; 1999 Mar; 17(11-12):1540-8. PubMed ID: 10195791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid.
    Borges E; Wiesmüller KH; Jung G; Walden P
    J Immunol Methods; 1994 Aug; 173(2):253-63. PubMed ID: 7519223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.
    Alving CR; Koulchin V; Glenn GM; Rao M
    Immunol Rev; 1995 Jun; 145():5-31. PubMed ID: 7590830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of the murine antibody response to an anti-CDR2 VH peptide on immunogen formulation.
    Kanda P; Fritz DA; Gage DA; Shuler KR
    Mol Immunol; 1995 Dec; 32(17-18):1319-28. PubMed ID: 8643101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A.
    White K; Rades T; Kearns P; Toth I; Hook S
    Pharm Res; 2006 Jul; 23(7):1473-81. PubMed ID: 16779706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.
    Tam JP
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5409-13. PubMed ID: 3399498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp41.
    Turánek J; Toman M; Novák J; Krchnák V; Horavová P
    Immunol Lett; 1994 Feb; 39(2):157-61. PubMed ID: 8013961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response.
    Wiesmüller KH; Bessler WG; Jung G
    Int J Pept Protein Res; 1992; 40(3-4):255-60. PubMed ID: 1282504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes.
    Boeckler C; Dautel D; Schelté P; Frisch B; Wachsmann D; Klein JP; Schuber F
    Eur J Immunol; 1999 Jul; 29(7):2297-308. PubMed ID: 10427993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-adjuvanting lipopeptide vaccines.
    Moyle PM; Toth I
    Curr Med Chem; 2008; 15(5):506-16. PubMed ID: 18289006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells.
    Lipford GB; Wagner H; Heeg K
    Vaccine; 1994 Jan; 12(1):73-80. PubMed ID: 8303944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system.
    Lu YA; Clavijo P; Galantino M; Shen ZY; Liu W; Tam JP
    Mol Immunol; 1991 Jun; 28(6):623-30. PubMed ID: 1861679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120.
    Nehete PN; Casement KS; Arlinghaus RB; Sastry KJ
    Cell Immunol; 1995 Feb; 160(2):217-23. PubMed ID: 7720083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.